The long-lasting improvement of sexual dysfunction in patients with advanced, fluctuating Parkinson's disease induced by pergolide: evidence from the results of an open, prospective, one-year trial-Reference-Cited by-同舟云学术

The long-lasting improvement of sexual dysfunction in patients with advanced, fluctuating Parkinson's disease induced by pergolide: evidence from the results of an open, prospective, one-year trial

Published:2005-12 Issue:8 Volume:11 Page:509-512
ISSN:1353-8020
Container-title:Parkinsonism & Related Disorders
language:en
Short-container-title:Parkinsonism & Related Disorders

Author:

Pohanka Michal,Kaňovský Petr,Bareš Martin,Pulkrábek Jirı́,Rektor Ivan

Publisher

Elsevier BV

Subject

Clinical Neurology,Geriatrics and Gerontology,Neurology

Reference33 articles.

1. Differential actions of antiparkinson agents at multiple classes of monoaminergic receptors. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes;Millan;J Pharmacol Exp Ther,2002

2. Differential actions of antiparkinson agents at multiple classes of monoaminoergic receptor. II. Agonist and antagonist properties at subtypes of dopamine D(2)-like receptor and alpha (1)/alpha(2) adrenoreceptor;Newman-Tancredi;J Pharmacol Exp Ther,2002

3. Double-blind controlled study of pergolide mesylate in the treatment of Parkinson's disease;Olanow;Clin Neuropharmacol,1987

4. The safety of pergolide monotherapy in early stage Parkinson's disease. One-year interim analysis of a 3-year double-blind, randomized study of pergolide versus levodopa;Hundemer;Mov Disord,2000

5. Pergolide monotherapy titration in Parkinson's disease;Nausieda;Mov Disord,2002

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Summary of the 2024 Update of the European Association of Urology Guidelines on Neuro-urology;European Urology;2024-06

2. Pergolide in the Treatment of Parkinson’s Disease;NeuroPsychopharmacotherapy;2022

3. Neurogenic Sexual Dysfunction Treatment: A Systematic Review;European Urology Focus;2020-09

4. Autonomic dysfunction in Parkinson’s disease: Implications for pathophysiology, diagnosis, and treatment;Neurobiology of Disease;2020-02

5. State-of-the-art pharmacotherapy for autonomic dysfunction in Parkinson’s disease;Expert Opinion on Pharmacotherapy;2020-01-20